Recerca sempre enfocada al pacient #Metastasis #sarcoma

Just got this from a European National Science Foundation after asking whether my work as an expert on the field would be paid. As for the manuscripts there is a moment to say NO #myworkisnotforfree And is also starting to happen in Spain. All of you know who I’m talking about

Join us for the third edition of the Oncobell Symposium, "New Frontiers in #CancerTherapies and #PersonalizedMedicine," on October 3rd and 4th! More info ➡️ oncobellsymposium.idibell.cat

Os presentamos el poster que el Grupo de investigación de Sarcomas del IDIBELL presentó en el congreso internacional de la Asociación Española de Investigación sobre el Cáncer ASEICA y en el que la APU es una de las entidades colaboradoras.

Being #CancerFreeIsntFree. Many childhood cancer survivors face late effects like heart and lung issues. Learn more about the possible struggles survivors face and retweet to help raise awareness: ow.ly/XNZP50SljKZ

Preprints need to gain more visibility. With the current review process they are years ahead of the conventional publishing record. If you are a funding body, pay reviewers to evaluate preprints to make them fully eligible as track record.

Organized by Puri Muñoz and Josep Maria Piulats Puri Muñoz Institut Català d'Oncologia And Oscar M Tirado, Bárbara Rivera, Mireia Olivan, Oriol Casanovas, Ruth Rodriguez Barrueco, Elisa Espinet, Albert Antolín, Cris Muñoz-Pinedo, Ernest Nadal Sarcomas IDIBELL Barbara Rivera @ProcureICO

A l'IDIBELL fem recerca que canvia vides❤️ Fa➕de 20 anys que treballem per ampliar el coneixement biomèdic i descobrir noves teràpies. 👩‍🔬I a tu, també et mouen els nostres reptes? 📽️youtube.com/watch?v=eOSpcf… Centres CERCA Salut Hospital Universitari Bellvitge | HUB Institut Català d'Oncologia Universitat de Barcelona Ajuntament de L'Hospitalet

Avui hem rebut la visita de l’alcalde de Viladecans, Carles Ruiz Novella /❤️, i diversos regidors del consistori, acompanyats de representants de l’Associació Viladecans contra el càncer. El Dr. Gabriel Capellá i Dr. Òscar M Tirado han compartit amb ells els nostres avenços en sarcomes.

oncodaily.com/insight/117698…

Avui he estat nomenat Secretari de Salut Pública #SSP de Catalunya Generalitat de Catalunya. Aparco la recerca i la docència a Institut Català d'Oncologia IDIBELL Universitat de Barcelona per seguir treballant per la salut pública. Agraït per la confiança i il·lusionat per la feina.

After more than 5 years we say goodbye to a wonderful scientist an person, Mariona Mariona Chicón-Bosch 🧬. May the force we with you little padawan. I’m sure you’ll succeed in this new adventure at Institut de Recerca Sant Joan de Déu they are lucky to have you! Thanks for the good times!

Looking forward to share results on our main line of research #sarcoma #metastasis DKFZ

We just got those magic words…. Dear Dr. Martínez Tirado: We are delighted to inform you that your manuscript, xxxxxx, has been accepted for publication. 🥹 #sarcoma #metastasis #mousemodel Soon we’ll share it.

Happy to finally share our last work doi.org/10.1002/1878-0… many thanks to everybody involved. Great effort by Roser Lopez Mariona Chicón-Bosch 🧬, Sarcomas IDIBELL and the collaborations of SilviaML and @GrunewaldLab #research #sarcoma #metastasis

Això es una repercusió de la feina que fa La Marató de 3Cat gràcies!

👏Step forward in understanding Ewing's sarcoma 🦴The Sarcomas research group Sarcomas IDIBELL, led by Dr. Òscar M. Tirado Oscar Martinez, finds key factors in the metastasis of the second most common bone tumor in children and young people 🔗idibell.cat/en/2025/01/ste…

🟢 Top news of #CataloniaHealth on January 2025🔝 tuit.cat/be7Tm vitalera AptadelTx Ship2B Ventures #WeAreCataloniaHealth

Dear Fundación Fero when 2 out of 8 reviewers wreck a proposal with poor or no arguments these evaluators must be excluded from the panel specially when the other six think the proposal is excelent! BTW this is also an advice for Contra el Cáncer Investigación ASEICA and many others.

After 18 years of success today we failed! Very dark days ahead for the group….#PID2024